The amount of occludin protein in TY09 was also significantly decreased after exposure to the sera from SPMS patients, although it was not changed after exposure to sera from RRMS-R or RRMS-S patients, or from healthy controls (Figs. 1A–F). This evidence concerns the gene OCLN and secondary progressive multiple sclerosis.